Assessment criteria for compensation of occupational bladder cancer - Abstract

In Germany, more than 100 bladder tumor cases are annually recognized as occupational disease and compensated, given that medical experts regard exposure to carcinogenic aromatic amines as a likely cause of cancer.

The amount of compensation is initially based on the tumor staging and grading at the time of initial diagnosis ("basic MdE") (MdE - reduction of earning capacity) and is adapted after a recurrence-free period of 2 and 5 years, respectively. In the event of treatment or tumor-related secondary conditions, the monthly compensation increases based on the severity of the objectified functional disorder. In the following article, medical experts specializing in this field provide a complete list of all known disorders, including treatment-related loss of a kidney or erectile dysfunction. In addition, the weighting of medical criteria in the assessment and calculation of the compensation is analyzed in greater detail. Since the given criteria are based on comprehensible experiences of urologists with their patients, they also provide medical experts in other countries with valuable points of reference for the calculation of the compensation.

Written by:
Schops W, Jungmann O, Zumbe J, Zellner M, Hengstler JG, Golka K.   Are you the author?
Leibniz Research Institute for Working Environment and Human Factors, Ardeystr. 67, 44139 Dortmund, Germany.

Reference: Front Biosci (Elite Ed). 2013 Jan 1;5:653-61.


PubMed Abstract
PMID: 23277020

UroToday.com Bladder Cancer Section